COAGULATION DISORDER
Clinical trials for COAGULATION DISORDER explained in plain language.
Never miss a new study
Get alerted when new COAGULATION DISORDER trials appear
Sign up with your email to follow new studies for COAGULATION DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer patients face double threat: clots and bleeding risks
Knowledge-focused CompletedThis study looked at how often cancer patients develop dangerous blood clots, especially those who also have bleeding problems or take blood thinners. Researchers followed 700 hospitalized cancer patients to track clot rates and understand risk factors. The goal was to gather inf…
Matched conditions: COAGULATION DISORDER
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 17, 2026 04:12 UTC
-
New blood clot drug put to the test in healthy volunteers
Knowledge-focused CompletedThis early-stage study looked at how a new drug called VMX-C001 interacts with common blood thinners (heparin and rivaroxaban) in 16 healthy adults. Researchers measured changes in blood clotting times to understand the drug's effects. The goal was to gather safety and activity d…
Matched conditions: COAGULATION DISORDER
Phase: PHASE1 • Sponsor: VarmX B.V. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
Fat emulsions and clotting: a large hospital observation
Knowledge-focused CompletedThis study looked at over 6,000 hospital patients to see if intravenous lipid emulsions (IV fats used in nutrition) change blood clotting. Researchers compared clotting test results from patients who received these emulsions with those who did not, using existing medical records.…
Matched conditions: COAGULATION DISORDER
Sponsor: Mimi Tang, PhD • Aim: Knowledge-focused
Last updated May 05, 2026 11:56 UTC